Other
HE
HE is an intervention with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Recruiting1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
recruiting125%
withdrawn125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
completednot_applicable
Pelviperineal Physiotherapy in Postpartum
NCT03247660
completednot_applicable
Project MOVE Bipolar
NCT07767032
recruitingnot_applicable
Effects of Invisalign Palatal Expander System
NCT06414863
withdrawnnot_applicable
Mohs and Immunofluorescence for Malignant Melanoma In Situ
NCT02306512
Clinical Trials (4)
Showing 4 of 4 trials
NCT03247660Not Applicable
Pelviperineal Physiotherapy in Postpartum
NCT07767032Not Applicable
Project MOVE Bipolar
NCT06414863Not Applicable
Effects of Invisalign Palatal Expander System
NCT02306512Not Applicable
Mohs and Immunofluorescence for Malignant Melanoma In Situ
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4